摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-Dimethylcyclohexanonethylenketal | 49673-67-8

中文名称
——
中文别名
——
英文名称
3,3-Dimethylcyclohexanonethylenketal
英文别名
7,7-dimethyl-1,4-dioxa-spiro[4.5]decane;7,7-Dimethyl-1,4-dioxaspiro[4.5]decane
3,3-Dimethylcyclohexanonethylenketal化学式
CAS
49673-67-8
化学式
C10H18O2
mdl
——
分子量
170.252
InChiKey
FJGHZROTGDFPRB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Bradykinin 1 Receptor Antagonists
    申请人:Zhu Jiawang
    公开号:US20090227601A1
    公开(公告)日:2009-09-10
    The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
    该发明涵盖了新型化合物及其药学上可接受的衍生物,药物组合物以及治疗由B1布雷因子受体介导的疾病的方法。
  • Herbicide and plant growth regulator comprising alpha-beta-unsaturated compound
    申请人:TEIJIN LIMITED
    公开号:EP0104432A2
    公开(公告)日:1984-04-04
    A herbicide comprising as an active ingredient an α,β-unsaturated compound of the following formula (I) wherein each of R' and R2 represents CN, NO2, a halogen, a C1-25 alkoxy or alkylthio, a group of the formula in which Z' represents C1-25 alkyl or a phenyl, a group of the formula in which X's represent an oxygen or sulfur atom and Z2 represents hydrogen, one equivalent of a cation, C1-25 alkyl, a phenyl or a phenyl (C1-25 alkyl), a group of the formula
    一种除草剂,其活性成分为下式(I)的α,β-不饱和化合物 其中 R'和 R2 各自代表 CN、NO2、卤素、C1-25 烷氧基或烷基代、一个式中的基团 其中 Z'代表 C1-25 烷基或苯基,一个式基团 式中 X 代表氧原子或原子,Z2 代表氢、一个当量的阳离子、C1-25 烷基、苯基或苯基(C1-25 烷基)、一个式基团
  • Chemical Compounds
    申请人:Pfizer Inc.
    公开号:US20210188829A1
    公开(公告)日:2021-06-24
    The invention relates to benzimidazoles of Formula (I) and pharmaceutically acceptable salts thereof, wherein R 1 to R 6 are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The benzimidazoles of Formula (I) are ITK inhibitors and are therefore potentially useful in the treatment of a wide range of disorders including, atopic dermatitis.
查看更多